top of page
  • Writer's pictureA2A Pharma


Updated: Feb 7, 2020

IndieBio - Designing Drugs insilico: An Interview with Ed Painter of A2A Pharmaceuticals

62 views0 comments

Recent Posts

See All

A2A co-founded biomea Fusion raises $56M

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of


bottom of page